发明公开
EP1165531A1 N-ADAMANT-1-YL-N'- 4-CHLOROBENZOTHIAZOL-2-YL] UREA USEFUL IN THE TREATMENT OF INFLAMMATION AND AS AN ANTICANCER RADIOSENSITIZING AGENT
审中-公开
的N-金刚烷-1-基 - ¬4氯 - 苯并噻唑-2-基脲FOR USE IN炎症的治疗并作为抗恶性肿瘤药RADIOSENSIBILISIERENDES
- 专利标题： N-ADAMANT-1-YL-N'- 4-CHLOROBENZOTHIAZOL-2-YL] UREA USEFUL IN THE TREATMENT OF INFLAMMATION AND AS AN ANTICANCER RADIOSENSITIZING AGENT
- 专利标题（中）： 的N-金刚烷-1-基 - ¬4氯 - 苯并噻唑-2-基脲FOR USE IN炎症的治疗并作为抗恶性肿瘤药RADIOSENSIBILISIERENDES
-
申请号： EP00915010.3申请日： 2000-03-15
-
公开(公告)号： EP1165531A1公开(公告)日： 2002-01-02
- 发明人: DUNCIA, John, J., V. , GARDNER, Daniel, S., IV. , SANTELLA, Joseph, B., III.
- 申请人： Du Pont Pharmaceuticals Company
- 申请人地址： Chestnut Run Plaza, 974 Centre Road Wilmington, DE 19807 US
- 专利权人： Du Pont Pharmaceuticals Company
- 当前专利权人： Du Pont Pharmaceuticals Company
- 当前专利权人地址： Chestnut Run Plaza, 974 Centre Road Wilmington, DE 19807 US
- 代理机构： Jones, Alan John
- 优先权： US125331P 19990319
- 国际公布： WO0056725 20000928
- 主分类号： C07D277/82
- IPC分类号： C07D277/82 ; A61K31/428 ; A61P29/00 ; A61P35/00
摘要：
This invention relates generally to N-adamant-1-yl-N'-[4-chlorobenzolthiazol-2-yl] urea, pharmaceutical compositions comprising the same, and methods of using the same in the treatment of inflammation and as an anticancer radiosensitizing agent.
信息查询
